A role for the NF-κB pathway in cell protection from complement-dependent cytotoxicity

Dana Gancz, Michal Lusthaus, Zvi Fishelson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Nucleated cells are equipped with several mechanisms that support their resistance to complement-dependent cytotoxicity (CDC). The role of the NF-κB pathway in cell protection from CDC was examined. Elevated sensitivity to CDC was demonstrated in cells lacking the p65 subunit of NF-κB or the IκB kinases IKKα or IKKβ, and in cells treated with p65 small interfering RNA. Pretreatment with the IKK inhibitor PS-1145 also enhanced CDC of wild-type cells (WT) but not of p65-/- cells. Furthermore, reconstitution of p65 into p65-/- cells and overexpression of p65 in WT cells lowered their sensitivity to CDC. The postulated effect of p65 on the JNK-mediated death-signaling pathway activated by complement was examined. p65 small interfering RNA enhanced CDC in WT cells but not in cells lacking JNK. JNK phosphorylation induced by complement was more pronounced in p65-/- cells than in WT cells. The results indicate that the NF-κB pathway mediates cell resistance to CDC, possibly by suppressing JNK-dependent programmed necrotic cell death.

Original languageEnglish
Pages (from-to)860-866
Number of pages7
JournalJournal of Immunology
Issue number2
StatePublished - 15 Jul 2012


Dive into the research topics of 'A role for the NF-κB pathway in cell protection from complement-dependent cytotoxicity'. Together they form a unique fingerprint.

Cite this